top of page

Profile

Join date: Dec 4, 2021

Posts (8)

Apr 17, 2026 ∙ 5 min
Osteosarcoma in the U.S. : Now Adding Cabozantinib to Standard Chemo to Break a Decades-Long Stalemate
<h2>What Is Osteosarcoma?</h2><p><strong>Osteosarcoma</strong> is the most common primary malignant bone tumor, accounting for approximately <strong>800–900 new cases annually</strong> in the United States. It primarily affects <strong>children, adolescents, and young adults</strong> (peak incidence in the second decade of life), with a second smaller peak in patients over 65. The tumor most frequently arises in the <strong>metaphysis of long bones</strong> — particularly the distal femur,...

26
0
Apr 16, 2026 ∙ 5 min
Malignant Mesothelioma Treatment in the US: Dual Immunotherapy Breaks a 16-Year Stalemate, Extending Survival to 18 Months
</style><h2>What Is Malignant Mesothelioma?</h2><p>Malignant mesothelioma is a cancer arising from the mesothelial cells lining the pleura, peritoneum, pericardium, or tunica vaginalis testis. In the United States, its incidence is approximately 0.6–1.0 per 100,000, with about 2,500–3,000 new diagnoses annually, making it one of the more prevalent rare solid tumors. The primary cause is prior asbestos exposure, with a latency period of 20–50 years; most patients are therefore over 60 at the...

6
0
Apr 16, 2026 ∙ 4 min
Metaplastic Breast Cancer in the U.S.: When Chemotherapy Fails, These Breakthrough Options Are Now Available
</style><h2>What Is Squamous Cell Carcinoma of the Anal Canal?</h2><p>Squamous cell carcinoma of the anal canal (SCAC) is a malignancy arising from the epithelium of the anal canal. In the United States, its incidence is approximately 2.0 per 100,000, with about 10,000 new diagnoses annually — making it one of the more prevalent rare cancers. The primary cause is persistent infection with human papillomavirus (HPV, particularly HPV-16/18); high-risk groups include HIV-positive individuals,...

10
0
medeboundmedebound

medebound

Editor
Admin
More actions
bottom of page